December 22, 2014 10:07 AM ET

Biotechnology

Company Overview of Palatin Technologies Inc.

Company Overview

Palatin Technologies, Inc., a biopharmaceutical company, develops peptide therapeutics for the treatment of diseases. The company’s clinical development product is Bremelanotide, a peptide melanocortin receptor agonist that has completed Phase 2B clinical trial for the treatment of female sexual dysfunction (FSD). Its drug development programs include Melanocortin receptor-1 agonist peptides for the treatment of inflammatory and dermatologic disease indications; Next Generation Melanocortin receptor-4 peptide agonists, which is in preclinical trials for the treatment of erectile dysfunction; and PL-3994, a natriuretic peptide receptor-A agonist that has completed Phase I clinical trial for t...

4B Cedar Brook Drive

Cranbury, NJ 08512

United States

Founded in 1986

17 Employees

Phone:

609-495-2200

Fax:

609-495-2201

Key Executives for Palatin Technologies Inc.

Co-Founder
Age: 52
Total Annual Compensation: $450.0K
Chief Financial Officer
Age: 57
Total Annual Compensation: $410.0K
Compensation as of Fiscal Year 2014.

Palatin Technologies Inc. Key Developments

Palatin Technologies Inc. Reports Consolidated Unaudited Earnings Results for the First Quarter Ended September 30, 2014

Palatin Technologies Inc. reported consolidated unaudited earnings results for the first quarter ended September 30, 2014. For the period, the company reported license revenue was $4,932,315. Income from operations was $893,888 compared with $4,492,650 for the same period last year. Net income was $794,674 or $0.01 diluted per share compared with net loss of $4,489,182 or $0.01 diluted per share for the same period last year. The increase in net income last fiscal year was mainly attributable to the recognition of $4.9 million in revenue pursuant to its agreement with Gedeon Richter.

Palatin Technologies Inc. to Report Q1, 2015 Results on Nov 18, 2014

Palatin Technologies Inc. announced that they will report Q1, 2015 results at 11:00 AM, US Eastern Standard Time on Nov 18, 2014

Palatin Technologies Inc., Q1 2015 Earnings Call, Nov 18, 2014

Palatin Technologies Inc., Q1 2015 Earnings Call, Nov 18, 2014

Similar Private Companies By Industry

Company Name Region
Nascent Biologics Inc. United States
Leptogen, Inc. United States
Meditope Biosciences, Inc. United States
Ambrx, Inc. United States
Novagen, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Palatin Technologies Inc., please visit www.palatin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.